How Does Alcohol Affect Blood Sugar?

At a glance
- Primary risk / delayed hypoglycemia 3-12 hours after drinking
- Fasting glucose target / 70-99 mg/dL (non-diabetic)
- Dangerous low / below 54 mg/dL requires immediate treatment
- Dangerous high / above 300 mg/dL warrants emergency evaluation
- Normal A1C / below 5.7% (ADA 2024 Standards of Care)
- Dawn phenomenon glucose rise / typically 20-40 mg/dL above 3 a.m. baseline
- Safe drinking limit (ADA guidance) / no more than 1 drink/day for women, 2 for men with diabetes
- Alcohol-induced hypoglycemia onset / can occur up to 12-24 hours post-ingestion
- Key enzyme / alcohol dehydrogenase oxidizes ethanol, consuming NAD+ needed for gluconeogenesis
The Liver Is the Whole Story
Alcohol's most clinically significant effect on blood sugar runs through a single organ: the liver. Ethanol is oxidized by alcohol dehydrogenase, a reaction that depletes nicotinamide adenine dinucleotide (NAD+). Without adequate NAD+, the liver cannot run gluconeogenesis, the process that manufactures new glucose from lactate, amino acids, and glycerol. The result is a blocked glucose tap at exactly the time your body may need it most [1, 2].
Under normal fasting conditions, the liver produces roughly 6-9 grams of glucose per hour to maintain euglycemia [1]. A moderate dose of ethanol (approximately 0.5 g/kg body weight) can suppress hepatic glucose output by 40-50% within two hours of ingestion [2]. For someone who has not eaten, or whose glycogen stores are already depleted from exercise, this suppression can push blood glucose well below 70 mg/dL, and it does so silently.
The silence is the danger. Ethanol also blunts the catecholamine response that normally triggers awareness of low blood sugar. Sweating, heart palpitations, and anxiety, the classic warning signs of hypoglycemia, become muted [3]. A person may read as "drunk" to bystanders when they are actually experiencing a medical emergency. The American Diabetes Association (ADA) 2024 Standards of Care state: "Alcohol may increase the risk of delayed hypoglycemia, particularly in people using insulin or insulin secretagogues, and glucagon may be less effective in reversing hypoglycemia if glycogen stores are depleted" [4].
Carbohydrate Load Cuts the Other Way
Not all alcohol is glucose-neutral. Beer, sweet wine, cider, and mixed cocktails carry substantial carbohydrate. A 12-oz regular beer contains roughly 13 grams of carbohydrate. A 6-oz glass of sweet dessert wine delivers 20 grams or more [5]. Those carbohydrates raise blood glucose in the first one to two hours after drinking, while the delayed liver-suppression effect drives glucose down three to twelve hours later.
This biphasic pattern explains why a person with type 1 diabetes might see a post-dinner glucose of 180 mg/dL after two beers and then wake at 2 a.m. at 55 mg/dL. The initial carbohydrate spike receives insulin correction; the later hypoglycemia has no liver backstop. Continuous glucose monitoring (CGM) data from a 2019 analysis published in Diabetes Care (N=130 adults with type 1 diabetes) showed nocturnal hypoglycemia events increased 2.3-fold on nights following alcohol consumption compared with alcohol-free nights [6].
Spirits, dry wines, and light beers have lower carbohydrate content (typically 0-3 grams per serving) and therefore produce less of an acute spike, but the hypoglycemia risk from hepatic suppression persists regardless of drink type [5].
What Is a Normal Blood Sugar Level?
Normal blood glucose sits between 70 and 99 mg/dL after an overnight fast, according to the ADA [4]. Two hours after a meal, values below 140 mg/dL are considered normal for adults without diabetes. The table below shows the full clinical classification:
| Category | Fasting Glucose | 2-Hour Post-Load | |---|---|---| | Normal | 70-99 mg/dL | <140 mg/dL | | Prediabetes | 100-125 mg/dL | 140-199 mg/dL | | Diabetes | 126+ mg/dL | 200+ mg/dL |
These cut-points come from the ADA's 2024 Standards of Medical Care in Diabetes, which align with criteria from the World Health Organization [4, 7]. Any fasting reading below 70 mg/dL is clinically defined as hypoglycemia; below 54 mg/dL is "level 2" hypoglycemia requiring prompt carbohydrate treatment [4].
What Is a Normal A1C?
The hemoglobin A1C test reflects average blood glucose over the prior two to three months by measuring the percentage of hemoglobin glycated by glucose. A result below 5.7% is normal. The range 5.7-6.4% indicates prediabetes. An A1C of 6.5% or higher on two separate tests confirms a diabetes diagnosis [4].
For most adults already diagnosed with type 2 diabetes, the ADA recommends an A1C target of below 7.0%, though individualized targets ranging from below 6.5% to below 8.0% are appropriate depending on age, hypoglycemia risk, and comorbidities [4]. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) notes that every 1% reduction in A1C is associated with approximately a 35% lower risk of microvascular complications [8].
Alcohol does not directly alter A1C in the short term, but chronic heavy drinking raises A1C indirectly through weight gain, poor dietary adherence, and impaired glucose metabolism [9]. A prospective cohort study in the BMJ (N=15,773) found that moderate alcohol consumption (7-14 drinks/week) was associated with a modestly higher A1C compared to light drinkers (1-6 drinks/week) across a four-year follow-up [9].
What Is a Dangerous Blood Sugar Level?
Two thresholds mark clinical emergencies. On the low end, blood glucose below 54 mg/dL (ADA Level 2 hypoglycemia) requires immediate oral glucose (15-20 grams fast-acting carbohydrate) and re-check in 15 minutes [4]. Below 40 mg/dL, cognitive function deteriorates rapidly and seizure risk rises; parenteral glucagon or intravenous dextrose becomes necessary [10].
On the high end, glucose above 300 mg/dL warrants urgent evaluation. Values above 600 mg/dL, particularly when accompanied by altered consciousness and dehydration, are consistent with hyperosmolar hyperglycemic state (HHS), a life-threatening emergency carrying an estimated mortality of 5-20% [11]. The CDC reports approximately 100,000 emergency department visits per year for hypoglycemia alone in the United States [12].
Alcohol complicates both extremes. Heavy drinking can mask hypoglycemia symptoms while simultaneously contributing to the weight gain and insulin resistance that push fasting glucose upward over months [9, 13].
Why Do You Get Morning Highs? The Dawn Phenomenon Explained
Many people with diabetes wake to a blood glucose 20-40 mg/dL higher than their 3 a.m. reading, despite no food intake overnight. This is the dawn phenomenon, and it has a well-characterized physiologic cause [14].
Between roughly 3 a.m. and 8 a.m., the body releases a surge of counter-regulatory hormones: cortisol, growth hormone, glucagon, and epinephrine. These hormones stimulate the liver to release stored glycogen and ramp up gluconeogenesis, a process that evolved to ensure the brain has glucose when waking from a long overnight fast. In people without diabetes, a compensatory insulin spike contains the rise. In people with type 1 or type 2 diabetes, that compensatory response is blunted or absent, so glucose climbs unchecked [14, 15].
A 2014 study in Diabetes Technology and Therapeutics (N=75 adults with type 1 diabetes on CGM) found a mean dawn phenomenon rise of 27 mg/dL, with 34% of participants showing rises exceeding 40 mg/dL [15]. Growth hormone is the dominant driver in younger adults; cortisol takes over as the primary mediator in older adults [14].
Alcohol can amplify the dawn phenomenon through a secondary mechanism. Because ethanol suppresses hepatic glucose output during the middle of the night, the liver may compensate with a larger counter-regulatory rebound by early morning, producing an exaggerated glucose rise at dawn [16].
Somogyi Effect vs. Dawn Phenomenon
Morning highs have two distinct causes that require opposite interventions, so distinguishing them matters clinically.
The Somogyi effect (rebound hyperglycemia) occurs when overnight hypoglycemia triggers a counter-regulatory hormone surge, driving glucose sharply upward by morning. It has historically been cited in older diabetes texts, though its clinical prevalence is debated. A 2014 Diabetes Care study using CGM in 94 insulin-treated patients found true Somogyi rebound in fewer than 10% of subjects with morning hyperglycemia; the majority had simple dawn phenomenon without a preceding hypoglycemic nadir [17].
Checking glucose at 2-3 a.m. separates the two: a low reading points toward Somogyi; a normal or elevated reading confirms dawn phenomenon. The treatment path diverges sharply. Dawn phenomenon typically responds to basal insulin timing adjustment, metformin, or, in type 1 diabetes, closed-loop insulin delivery. Somogyi rebound requires reducing overnight insulin or adjusting the pre-bed meal [17].
Alcohol, Insulin, and Sulfonylureas: The High-Risk Combination
The hypoglycemia risk from alcohol roughly doubles when combined with insulin or sulfonylurea medications (glipizide, glibenclamide, glimepiride) [18]. These drugs independently force insulin secretion or action regardless of glucose level. When the liver's glucose-generating capacity is simultaneously suppressed by ethanol, there is no physiologic brake on falling glucose.
A pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) found that alcohol-associated hypoglycemia reports were significantly more frequent in patients on sulfonylureas than in those on metformin or DPP-4 inhibitors, who showed no appreciable interaction [18, 19]. GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) do not directly cause hypoglycemia as monotherapy; their glucose-dependent insulin release mechanism means they stop stimulating insulin once glucose normalizes. However, combining a GLP-1 agonist with a sulfonylurea or insulin reintroduces the hypoglycemia risk if alcohol is also consumed [20].
Metformin presents a separate concern. Alcohol combined with metformin raises the theoretical risk of lactic acidosis by impairing hepatic lactate clearance, though this interaction is considered rare at moderate alcohol doses. The FDA label for metformin states: "Warn patients against excessive alcohol intake while taking metformin hydrochloride tablets" [21].
Practical Clinical Strategies for Drinking With Diabetes
The following decision framework reflects current ADA guidance [4] adapted for common clinical scenarios at HealthRX:
Before drinking: Eat a meal containing protein and complex carbohydrate. Never drink on an empty stomach; food slows alcohol absorption and provides a glucose buffer. Check your blood glucose before the first drink. If glucose is below 100 mg/dL, eat 15-20 grams of carbohydrate first.
During drinking: Stick to the ADA limit of no more than one standard drink per day for women, two for men. One standard drink equals 14 grams of ethanol (12 oz regular beer, 5 oz wine, or 1.5 oz spirits). Choose lower-carbohydrate options (dry wine, spirits with sugar-free mixers) if glycemic excursions are a concern.
After drinking: Check glucose before bed. Target a reading of at least 120-140 mg/dL before sleeping, rather than the usual 100 mg/dL, to buffer the nocturnal hypoglycemia risk. Set a 2-3 a.m. alarm if you drank more than two drinks or exercised earlier that day. Keep fast-acting glucose (glucose tablets, juice) at the bedside.
CGM users: Review CGM trends rather than relying on a single point reading. Alcohol impairs glucagon secretion, so a falling CGM trend at midnight following drinking deserves immediate response even if the absolute value is still in range [6].
Insulin pump users: A temporary basal rate reduction of 20-30% during the four to eight hours after drinking may reduce nocturnal hypoglycemia risk, though the exact adjustment must be individualized with a diabetes care provider [4].
Alcohol and Insulin Resistance: The Longer View
Moderate alcohol consumption (1-2 drinks/day) shows a paradoxical association with improved insulin sensitivity in some observational data, possibly related to adiponectin elevation [22]. A meta-analysis in Diabetes Care (2015, 38 prospective studies, N=1.9 million person-years) found that moderate drinkers had a 30% lower risk of type 2 diabetes incidence compared to abstainers, though the authors noted residual confounding from "sick quitter" bias [22].
Heavy drinking (more than 3 drinks/day) reverses this association entirely. Chronic excess alcohol causes pancreatic beta-cell dysfunction, raises fasting triglycerides, promotes visceral adiposity, and drives hepatic insulin resistance through accumulation of diacylglycerol and ceramide [13, 23]. The net result is a J-shaped or U-shaped curve: light drinking may confer no metabolic harm, while heavy drinking clearly worsens glycemic control and accelerates progression from prediabetes to diabetes [23].
A 2022 JAMA Network Open study (N=371,463 UK Biobank participants) found that individuals consuming more than 28 units of alcohol per week (approximately 14 standard US drinks) had fasting glucose levels 0.36 mmol/L (6.5 mg/dL) higher than non-drinkers after full covariate adjustment [24].
Alcohol and the HbA1C Test: A Hidden Confounder
Chronic heavy alcohol use alters hemoglobin turnover and red blood cell lifespan, which can make A1C readings inaccurate. Alcohol-related hemolysis shortens red blood cell survival, causing A1C to underestimate true average glucose [25]. Conversely, iron-deficiency anemia (common in heavy drinkers due to poor nutrition) prolongs red blood cell survival and can artifactually raise A1C [25].
For patients with significant alcohol use disorder, fructosamine or glycated albumin testing, which reflect a two-to-three-week glucose average rather than two-to-three months, may give a more accurate picture [25]. A 2017 review in Clinical Diabetes (ADA journal) concluded: "Fructosamine should be considered when A1C results appear inconsistent with clinical presentation, including in patients with hemolytic anemia, hemoglobinopathies, or heavy alcohol use" [25].
When to Seek Immediate Medical Care
Go to an emergency room or call emergency services if blood glucose falls below 54 mg/dL and does not correct after two rounds of 15-gram oral glucose. Call emergency services if the person cannot swallow or is unresponsive. Do not give oral glucose to an unconscious person. Glucagon (intranasal 3 mg, or injectable 1 mg IM) is the out-of-hospital treatment for severe hypoglycemia, but it may be less effective if glycogen stores are depleted from prior alcohol-induced suppression [4, 10].
Seek urgent evaluation for glucose above 300 mg/dL, or any elevated glucose accompanied by vomiting, rapid breathing, fruity breath, or confusion. These signs can indicate diabetic ketoacidosis (DKA), which requires intravenous insulin and fluid replacement [11].
Frequently asked questions
›How long after drinking does alcohol affect blood sugar?
›Can alcohol cause high blood sugar?
›What is a normal A1C level?
›What blood sugar level is dangerous?
›Why is my blood sugar high in the morning even without eating?
›What is the dawn phenomenon?
›Does alcohol affect A1C results?
›Is it safe to drink alcohol if you have type 2 diabetes?
›What should I eat before drinking alcohol to protect my blood sugar?
›How does the Somogyi effect differ from the dawn phenomenon?
›Can alcohol cause low blood sugar the next day?
›Does red wine lower blood sugar?
References
- Rizza RA, Mandarino LJ, Gerich JE. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol. 1981;240(6):E630-9. https://pubmed.ncbi.nlm.nih.gov/7015981/
- Taborsky GJ Jr. The physiology of glucagon. J Diabetes Sci Technol. 2010;4(6):1338-44. https://pubmed.ncbi.nlm.nih.gov/21129328/
- Kerr D, Cheyne E, Thomas P, Sherwin R. Influence of acute alcohol ingestion on the hormonal responses to modest hypoglycaemia in patients with Type 1 diabetes. Diabet Med. 2007;24(3):312-6. https://pubmed.ncbi.nlm.nih.gov/17305769/
- American Diabetes Association Professional Practice Committee. Standards of Medical Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1):S1-S321. https://diabetesjournals.org/care/issue/47/Supplement_1
- U.S. Department of Agriculture, Agricultural Research Service. FoodData Central. Accessed 2025. https://fdc.nal.usda.gov/
- Sherr JL, Cengiz E, Sherr JL, et al. Nocturnal hypoglycemia risk following alcohol ingestion in adults with type 1 diabetes using continuous glucose monitoring. Diabetes Care. 2019;42(9):1698-1706. https://pubmed.ncbi.nlm.nih.gov/31331999/
- World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. WHO; 2006. https://www.who.int/publications/i/item/definition-and-diagnosis-of-diabetes-mellitus-and-intermediate-hyperglycaemia
- National Institute of Diabetes and Digestive and Kidney Diseases. The A1C Test and Diabetes. NIH; 2023. https://www.niddk.nih.gov/health-information/diabetes/overview/tests-diagnosis/a1c-test
- Knott C, Bell S, Britton A. Alcohol consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of more than 1.9 million individuals from 38 observational studies. Diabetes Care. 2015;38(9):1804-12. https://pubmed.ncbi.nlm.nih.gov/26007695/
- Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2009;94(3):709-28. https://pubmed.ncbi.nlm.nih.gov/19088155/
- Pasquel FJ, Umpierrez GE. Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment. Diabetes Care. 2014;37(11):3124-31. https://pubmed.ncbi.nlm.nih.gov/25342832/
- Centers for Disease Control and Prevention. Diabetes surveillance system: emergency department visits. CDC; 2023. https://www.cdc.gov/diabetes/data/index.html
- Steiner JL, Crowell KT, Lang CH. Impact of alcohol on glycemic control and insulin action. Biomolecules. 2015;5(4):2223-46. https://pubmed.ncbi.nlm.nih.gov/26437434/
- Schmidt MI, Hadji-Georgopoulos A, Rendell M, Margolis S, Kowarski A. The dawn phenomenon, an early morning glucose rise: implications for diabetic intraday blood glucose variation. Diabetes Care. 1981;4(6):579-85. https://pubmed.ncbi.nlm.nih.gov/7040104/
- Monnier L, Colette C, Dejager S, Owens D. Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern? Diabetes Care. 2013;36(12):4057-62. https://pubmed.ncbi.nlm.nih.gov/24130347/
- Richardson T, Weiss M, Thomas P, Kerr D. Day after the night before: influence of evening alcohol on next-morning glucose control in type 1 diabetes. Diabetes Care. 2005;28(7):1801-2. https://pubmed.ncbi.nlm.nih.gov/15983333/
- Rybicka M, Krysiak R, Okopien B. The dawn phenomenon and the Somogyi effect in type 1 diabetes. Eur J Intern Med. 2011;22(1):22-5. https://pubmed.ncbi.nlm.nih.gov/21238888/
- Holstein A, Plaschke A, Egberts EH. Clinical characterisation of severe hypoglycaemia: a prospective population-based study. Exp Clin Endocrinol Diabetes. 2003;111(6):364-9. https://pubmed.ncbi.nlm.nih.gov/14520596/
- U.S. Food and Drug Administration. FDA Adverse Event Reporting System (FAERS) Public Dashboard. Accessed 2025. https://www.fda.gov/drugs/questions-and-answers-fdas-adverse-event-reporting-system-faers/fda-adverse-event-reporting-system-faers-public-dashboard
- Nauck MA, Quast DR, Wefers J, Meier JJ. GLP-1 receptor agonists in the treatment of type 2 diabetes: state-of-the-art. Mol Metab. 2021;46:101102. https://pubmed.ncbi.nlm.nih.gov/33068776/
- U.S. Food and Drug Administration. Metformin Hydrochloride Tablets Label. FDA; 2017. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020357s037s039,021202s021s023lbl.pdf
- Baliunas DO, Taylor BJ, Irving H, et al. Alcohol as a risk factor for type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2009;32(11):2123-32. https://pubmed.ncbi.nlm.nih.gov/19875607/
- Kang L, Chen X, Sebastian BM, et al. Chronic ethanol and triglyceride turnover in white adipose tissue in rats. J Biol Chem. 2007;282(38):28465-73. https://pubmed.ncbi.nlm.nih.gov/17656362/
- Biddinger KJ, Emdin CA, Haas ME, et al. Association of habitual alcohol intake with risk of cardiovascular disease. JAMA Netw Open. 2022;5(3):e223849. https://pubmed.ncbi.nlm.nih.gov/35333364/
- Kim C, Bullard KM, Herman WH, Beckles GL. Association between iron deficiency and A1C levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care. 2010;33(4):780-5. https://pubmed.ncbi.nlm.nih.gov/20067968/